IHC - WT-1 Test, Price, Normal Range | Sprint Diagnostics Hyderabad

Patient Preparing : No specific preparation is necessary before this test. As usual, patients should maintain their regular diet and medication schedule unless advised differently by their healthcare provider.

₹ 2000


The IHC - WT-1 (Wilms' Tumor-1) Diagnostic Test is an important tool in the world of medical diagnostics, especially when it comes to identifying certain types of cancer. WT-1 is a protein that is usually present in kidney cells during fetal development but is rarely found in adult kidney cells.

The IHC - WT-1 test utilizes a technique known as immunohistochemistry (IHC) to identify the presence of specific proteins such as WT-1 in tissue samples. This test is particularly useful in diagnosing and classifying certain types of kidney and ovarian cancers.

Test Name IHC - WT-1
Sample Type Tissue
Preparations Required No specific preparation is necessary before this test. As usual, patients should maintain their regular diet and medication schedule unless advised differently by their healthcare provider.
Report Time 3 days
Price in Hyderabad ₹ 2000

Home Sample Collection

Confirm Your Slot
Book your convenient slot
Agent Visits To Your Home
Sample Collection by Phlebotomist
Testing Done At Lab
Reporting of the sample at lab
Download Report
Download Reports

HOMA Index Insulin Resistance Test

Popular Tests

Complete Blood Count (CBC)
Complete Blood Count
Know More
Vitamin B12
Vitamin B12
Know More
Liver Function Test (LFT)
Liver Function Test (LFT)
Know More
Glucose Tolerance Test - Extended
Glucose Tolerance Test - Extended
Know More

Why is the IHC - WT-1 Diagnostic Test important?

The IHC - WT-1 test is crucial in diagnosing specific types of cancer, such as Wilms' tumor (a type of kidney cancer commonly seen in children), and certain types of ovarian cancers. The results can influence clinical decisions regarding prognosis and treatment.

Do I need to fast before this test?

No, fasting is not necessary for this test, as it involves the analysis of tissue samples, not blood.

When should this test be done?

This test is generally performed when a patient has been diagnosed with a tumor, and there is a need to identify the primary site, particularly when a kidney or ovarian origin is suspected.

What information does this test provide?

The IHC - WT-1 test identifies the presence of the WT-1 protein in tissue samples. A positive result can suggest that the sampled tumor originated from kidney or ovarian tissues, helping to classify the type of cancer.

How often should this test be done?

The frequency of this test is based on the individual's clinical circumstances and should be advised by their healthcare provider.

What are the normal values for this test?

In tissue samples, 'normal' values are not strictly applicable. The interpretation of results should be performed by a healthcare provider in the context of the patient's overall clinical picture.

What precautions should I take before the test?

No special precautions are necessary before this test. Patients should continue with their usual diet and medications unless instructed otherwise by their healthcare provider.

What factors could affect WT-1 levels?

WT-1 levels can be influenced by the presence and type of cancer, specifically kidney and certain types of ovarian cancers.

What should I do if my test results are abnormal?

If your test results are abnormal, it is advisable to discuss them with an oncologist or the healthcare provider who ordered the test. They can interpret the results in the context of your overall health condition and guide further investigations or treatments as required.

Are there any risks associated with this test?

The risks associated with this test primarily involve the biopsy procedure used to obtain the tissue sample. These may include discomfort, bleeding, or infection.

Can medications affect the test results?

Currently, there are no known medications that specifically influence WT-1 levels.

Is the IHC - WT-1 test used solely for diagnosing cancers?

While the primary use of the IHC - WT-1 test is in the diagnosis and classification of certain cancers, it may also be utilized in specific clinical situations or research as determined by a healthcare provider.

What happens if the test result is positive?

A positive result for the IHC - WT-1 test indicates the presence of the WT-1 protein in the tissue sample. This result can suggest the presence of certain types of cancers, particularly Wilms' tumor or certain ovarian cancers. However, further interpretation should be made by a healthcare provider considering the overall clinical context.

Are there other tests typically performed alongside this one?

Yes, the IHC - WT-1 test is often part of a larger panel of tests, including other IHC markers and possibly genetic tests, to diagnose and classify tumors accurately.

Who performs the IHC - WT-1 test?

This test is performed by a pathologist in a laboratory setting.

Is this test recommended for both men and women?

Yes, this test can be performed on both men and women if there is a need to evaluate for certain types of tumors. However, since WT-1 is often used in diagnosing certain ovarian cancers, it may be more commonly used in women.

Can this test be used for conditions other than cancers?

While the primary use of the IHC - WT-1 test is in the assessment of certain cancers, it may be used in other specific clinical situations or research as determined by a healthcare provider.

Can lifestyle changes affect the test results?

While maintaining a healthy lifestyle is always beneficial, it does not directly influence WT-1 levels, which are primarily determined by the presence of specific cancers.

Is the IHC - WT-1 test painful?

The test itself is not painful. However, the biopsy procedure used to obtain the tissue sample can cause some discomfort.

Can the IHC - WT-1 test predict how well I will respond to treatment?

The IHC - WT-1 test can provide useful information for the classification of certain cancers, which can guide treatment decisions. However, individual responses to treatment involve many factors and should be discussed with your healthcare provider.

In summary, the IHC - WT-1 Diagnostic Test is an essential tool in the diagnosis and management of certain types of cancers, particularly Wilms' tumor and certain ovarian cancers. Always consult your healthcare provider for a thorough interpretation of your test results and guidance on the next steps for your health journey.

Book Your Slot

Our Locations Near You in Hyderabad
4KM from Madhapur
3KM from Banjara Hills
1.9KM from Yusufguda
3KM from Madhura Nagar
5KM from Shaikpet
Live Chat